Back to Trades
Anzalone Christopher Richard
Chief Executive OfficerDirectorCIK 0001423029
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 21
- Companies
- 1
- Active
- 2025–2026
Anzalone Christopher Richard, Chief Executive Officer, Director, accounts for 4 disclosed filings worth $19.2M, all concentrated in ARROWHEAD PHARMACEUTICALS, INC. (ARWR), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $18.6M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jan 5 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell | $871.7K |
| Dec 30 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell | $3.6M |
| Dec 23 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell | $1.8M |
| Dec 16 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell | $12.3M |
4 filings